Hypoxia is caused by dysregulated vascularization and vigorous metabolic activity; it is a major tumor microenvironmental cause of sorafenib resistance in HCC via HIF1α and nuclear factor kappa B (NF-κB) activation [12,13,14]. Here, HIF1A is linked to hepatocellular carcinoma.